Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-17 4:05 pm Purchase | 13D | AVENUE THERAPEUTICS INC PA ATXI | Fortress Biotech Inc. FBIO | 3,564,059 8% | 2,515,003 (+239.74%) | View |
| 2024-03-22 6:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,796,278 7.5% | 352,039 (+14.40%) | View |
| 2024-02-14 4:51 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 372,562 4.2% | -7,595,494 (-95.32%) | View |
| 2024-01-03 4:41 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | ROSENWALD LINDSAY A MD | 2,813,905 15.3% | 216,465 (+8.33%) | View |
| 2023-11-21 4:09 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | WEISS MICHAEL S | 1,130,520 7.6% | 1,130,520 (New Position) | View |
| 2023-11-21 4:08 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | ROSENWALD LINDSAY A MD | 2,597,440 17.5% | 2,597,440 (New Position) | View |
| 2023-09-26 4:16 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,444,239 11.3% | 80,906 (+3.42%) | View |
| 2023-09-18 5:08 pm Purchase | 13D | AVENUE THERAPEUTICS INC PA ATXI | Fortress Biotech Inc. FBIO | 1,049,056 12.1% | 1,049,056 (New Position) | View |
| 2023-07-06 4:44 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,363,333 13.6% | 81,406 (+3.57%) | View |
| 2023-04-19 4:24 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,281,927 17.5% | 78,214 (+3.55%) | View |
| 2023-02-14 5:01 pm Sale | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 7,968,056 7.3% | -1,117,949 (-12.30%) | View |
| 2023-02-14 4:35 pm Purchase | 13D | FORTRESS BIOTECH INC FBIO | KATZ DARYL | 6,052,975 4.76% | 445,604 (+7.95%) | View |
| 2023-02-09 11:19 am Sale | 13G | FORTRESS BIOTECH INC FBIO | VANGUARD GROUP INC | 5,104,407 4.7% | -585,867 (-10.30%) | View |
| 2023-01-13 4:13 pm Purchase | 13D | MUSTANG BIO INC MBIO | Fortress Biotech Inc. FBIO | 22,880,620 20.7% | 22,880,620 (New Position) | View |
| 2023-01-13 4:13 pm Purchase | 13D | CHECKPOINT THERAPEUTICS INC CO CKPT | Fortress Biotech Inc. FBIO | 2,203,713 19.3% | 2,203,713 (New Position) | View |
| 2023-01-06 4:31 pm Sale | 13D | AVENUE THERAPEUTICS INC NE ATXI | Fortress Biotech Inc. FBIO | 578,227 11.3% | -3,261,869 (-84.94%) | View |
| 2022-08-17 4:01 pm Purchase | 13G | JOURNEY MED CORP COM DERM | Fortress Biotech Inc. FBIO | 10,010,467 56.9% | 10,010,467 (New Position) | View |
| 2022-02-14 08:13 am Purchase | 13G | FORTRESS BIOTECH INC FBIO | Nantahala Capital Management LLC | 9,086,005 9.6% | 405,096 (+4.67%) | View |
| 2022-02-10 08:11 am Purchase | 13G | FORTRESS BIOTECH INC FBIO | VANGUARD GROUP INC | 5,690,274 5.71% | 5,690,274 (New Position) | View |
| 2021-05-07 5:09 pm Purchase | 13G | FORTRESS BIOTECH INC FBIO | BlackRock Inc. BLK | 4,814,223 5% | 94,943 (+2.01%) | View |